Kamalia
Halid, Iswanto Pratanu
Silent myocardial
ischemia (SMI) is an objective documented ischemia in the absence of chest
discomfort or other angina equivalents and is major component of the total
ischemic burden for patient with ischemic heart disease. It is estimated that
between 2 and 3 million persons with stable CAD have evidence of silent
ischemia. Contributing to this statistic is the observation that the majority
of myocardial ischemic episodes are silent, indicating an inability or failure
to sense ischemic damage or stress an the heart. Although many diagnostic tools
have been used to identify, their use is limited by modest sensitivities and
spesificities. Management SMI with anti-ischemic drug therapy or
revascularization reduced the long-term risk of major cardiac events based on
some clinical evidenced. Future studied aimed at improving the management of
silent ischemia in the population is warranted to make better prognosis.
Lihat
disini
